CompanyRLYBNasdaqNew Haven, CT

Rallybio Corp

Rallybio is a clinical-stage biotech company developing complement and hematology therapies.

SEC EDGAR ClinicalTrials.gov avenzotx.com

8-KSep 9Latest SEC filing, period to Sep 8

Sep 9Latest story

September 2026

Rallybio CFO Jonathan Lieber shifts to part-time role ahead of Avenzo merger

Sep 9PeopleRallybio Corp